Profile data is unavailable for this security.
About the company
PT Metro Healthcare Indonesia Tbk is an Indonesia-based company. The Company operates its business in an integrated health service with hospital under Metro Hospital Group. It is focused on developing technology-based health services and training centers to produce professionals in health services. The Company’s hospitals consist of mother and child hospitals and type B, type C, and type D general hospitals. The Company offers healthcare service with a range of services and facilities including polyclinic, ICU room, class III inpatient room and Super VIP room ready to cater various type of patients. The Company operates RSIA Bunda Sejahtera, RSU Bina Sehat Mandiri, RSU Metro Hospitals Cikarang, RSU Metro Hospitals Cikupa, RSU Kartini, and RSIA Santo Yusuf. Its subsidiaries include PT Metro Global Medika, PT Metro Healthcare Technologies, PT Metro Medika Abadi, PT Mitra Adika Buana, PT Indah Nusa Indonesia, PT Sejahtera Berkah Berdikari and PT Berkarya Sejahtera Gemilang.
- Revenue in IDR (TTM)277.24bn
- Net income in IDR-100.91bn
- Incorporated--
- Employees772.00
- LocationMetro Healthcare Indonesia Tbk PTJl. Raya Km 16,8 RT/RW 005/001Kelurahan Sukamulya, Kecamatan Cikupa, KTANGERANG 15710IndonesiaIDN
- Phone+62 2 159647937
- Fax+62 2 159647871
- Websitehttps://www.metrohealthcareindonesia.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Charlie Hospital Semarang PT | -100.00bn | -100.00bn | 567.10bn | 208.00 | -- | 3.76 | -- | -- | -- | -- | -- | 56.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.72 | -- | 0.00 | -- | 27.63 | -- | 84.88 | -- | -- | -- |
| Kedoya Adyaraya Tbk PT | 399.43bn | 32.74bn | 757.69bn | 721.00 | 18.07 | 0.9894 | 11.70 | 1.90 | 45.10 | 45.10 | 560.39 | 823.71 | 0.4486 | 17.47 | 9.38 | 573,076,700.00 | 3.67 | 2.72 | 4.04 | 3.27 | 37.12 | 37.45 | 8.18 | 6.33 | 1.92 | -- | 0.00 | -- | 3.97 | 8.97 | -3.79 | 25.02 | -15.14 | -- |
| Bundamedik Tbk PT | 1.52tn | 8.38bn | 2.56tn | 1.43k | 306.02 | 1.60 | 18.77 | 1.69 | 0.9738 | 0.9738 | 176.27 | 186.08 | 0.4975 | 18.91 | 11.65 | 1,057,541,000.00 | 0.6324 | 5.66 | 0.8676 | 8.03 | 46.75 | 47.33 | 1.27 | 9.08 | 1.45 | 2.22 | 0.3885 | -- | -10.28 | 11.79 | -91.04 | 7.79 | 5.32 | -- |
| Murni Sadar Tbk PT | 966.99bn | -8.44bn | 2.56tn | 3.19k | -- | 2.27 | 20.22 | 2.65 | -3.50 | -3.50 | 463.19 | 546.96 | 0.5264 | 22.83 | 6.75 | 359,341,000.00 | -0.5225 | 1.65 | -0.6336 | 2.07 | 25.09 | 30.31 | -0.9925 | 2.64 | 0.5239 | 0.5022 | 0.3242 | -- | 12.12 | 22.03 | -119.46 | -- | -5.48 | -- |
| Metro Healthcare Indonesia Tbk PT | 277.24bn | -100.91bn | 2.69tn | 772.00 | -- | 0.876 | -- | 9.71 | -3.03 | -3.03 | 8.34 | 92.46 | 0.0669 | 45.43 | 9.47 | 373,635,900.00 | -2.43 | -1.25 | -2.80 | -1.34 | 35.75 | 43.83 | -36.30 | -17.88 | 0.844 | -0.3986 | 0.2354 | -- | -6.81 | 22.71 | -18.58 | -- | -43.34 | -- |
| Prodia Widyahusada Tbk PT | 2.19tn | 227.50bn | 2.77tn | 2.96k | 12.16 | 1.16 | 6.68 | 1.26 | 242.66 | 242.66 | 2,337.59 | 2,545.31 | 0.8068 | 23.70 | 14.85 | 740,868,800.00 | 8.35 | 14.52 | 9.02 | 15.93 | 59.17 | 59.64 | 10.35 | 16.24 | 6.85 | -- | 0.0121 | 58.71 | 1.87 | 6.80 | -30.08 | 8.17 | 5.10 | 12.14 |
| Sarana Meditama Metropolitan Tbk PT | 1.61tn | 11.94bn | 4.32tn | 2.71k | 365.85 | 1.19 | 17.82 | 2.69 | 0.6888 | 0.6888 | 93.48 | 212.30 | 0.3031 | 20.67 | 6.83 | 614,934,500.00 | 0.3575 | -0.946 | 0.4268 | -1.12 | 34.69 | 37.04 | 1.18 | -3.46 | 0.7997 | 1.41 | 0.1962 | -- | 10.20 | 10.03 | 181.84 | -26.95 | 1.03 | -- |
| Famon Awal Bros Sedaya Tbk PT | 1.84tn | 216.97bn | 8.45tn | 5.62k | 38.93 | 3.02 | 20.75 | 4.59 | 15.54 | 15.54 | 131.73 | 200.48 | -- | -- | -- | 327,091,000.00 | -- | -- | -- | -- | 28.24 | -- | 12.18 | -- | 3.47 | -- | 0.3034 | -- | 20.79 | -- | 247.14 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 06 Jun 2024 | 378.57m | 1.14% |
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 144.20m | 0.43% |
| BlackRock Advisors (UK) Ltd.as of 06 Jun 2024 | 76.02m | 0.23% |
| TIAA-CREF Investment Management LLCas of 30 Apr 2024 | 13.12m | 0.04% |
| Asset Management One Co., Ltd.as of 24 Nov 2022 | 13.08m | 0.04% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 5.47m | 0.02% |
| DFA Australia Ltd.as of 31 May 2024 | 3.31m | 0.01% |
| BlackRock Institutional Trust Co. NAas of 06 Jun 2024 | 2.32m | 0.01% |
| Dimensional Fund Advisors Ltd.as of 30 Apr 2024 | 2.25m | 0.01% |
| Northern Trust Investments, Inc.(Investment Management)as of 07 Jun 2024 | 286.70k | 0.00% |
